Review of phosphatidylserines health benefits in Parkinson’s disease and students survey

LaNisha Potts, Alvina Okafor, Ayona Shelton and Bisrat Hailemeskel *

Clinical & Administrative Pharmacy Sciences, College of Pharmacy, Howard University, Washington, USA. 
 
Review
International Journal of Science and Research Archive, 2023, 09(01), 027–033.
Article DOI: 10.30574/ijsra.2023.9.1.0340
Publication history: 
Received on 13 March 2023; revised on 30 April 2023; accepted on 01 May 2023
 
Abstract: 
The goal of this study is two folds: to conduct a literature review of the beneficial use of phosphatidylserine in Parkinson’s Disease (PD) and to determine the knowledge base and opinion of pharmacy students. The literature search that was conducted revealed there are only very few clinical studies found that show the beneficial effect of phosphatidylserine in PD. The students’ survey conducted was among 42 first-year professional pharmacy students. The goal was to gain insight into if they had knowledge of the supplement phosphatidylserine in PD. The survey data was analyzed using SPSS software. Results show that the participants have limited overall knowledge of the topic. The results from the opinion questions also varied highly among the participants. Demographic factors of age, educational level, and work experiences affected the outcome significantly. For example, the higher the age, education level, and number of years worked the more likely the participant believed phosphatidylserine would help with the treatment of PD. A few studies have shown the use of supplements is beneficial for cognitive disorders; however, none are showing the knowledge status of this usage amongst healthcare professionals. Based on studies reviewed, phosphatidylserine may be beneficial in slowing the progression of PD. That may be one of the reasons for the students’ limited knowledge shown in this study.
 
Keywords: 
Phosphatidylserine; Parkinson’s Disease; Pharmacy; Students; Survey Introduction
 
Full text article in PDF: 
 
Copyright information: 

Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0